Diabetes Forecast

New Glucagon Powder Nasal Spray Approved

By Miriam E. Tucker , , ,

Eli Lilly and Co.

Goodbye, complicated glucagon shots. The Food and Drug Administration has approved a nasal form of the rescue medication. When people with diabetes are unable to treat severe hypoglycemia with fast-acting carb (if they’re unconscious, for instance), glucagon raises blood glucose to a safe level. Until now, the drug could only be given by a cumbersome injection that requires several steps to prepare. Baqsimi, Eli Lilly and Co.’s new glucagon powder, comes in a plunger device that a companion can simply spray into the person’s nose. (Notably, it doesn’t need to be inhaled to work.) It raises blood glucose just as well as injected glucagon and is approved for use in people ages 4 and older.
Source: Food and Drug Administration, July 24, 2019



Take the Type 2
Diabetes Risk Test